Kymera Therapeutics Announces Late-Breaking Oral Presentation of KT-621 Phase 1b Data at the American Academy of Dermatology (AAD) Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/3/2026

1. KRG
2. CCH:LN
3. META
4. CCHGY
5. PRY:IM
6. PRYMY
7. SPY
8. SKA-B
9. PBA
10. ALAR

Go back to Kymera Therapeutics Announces Late-Breaking Oral Presentation of KT-621 Phase 1b Data at the American Academy of Dermatology (AAD) Annual Meeting
(NASDAQ: KYMR) Delayed: 113.51 -0.69 (0.6%)
Previous Close $114.20    52 Week High $ 
Open $115.06    52 Week Low $ 
Day High $115.47    P/E N/A 
Day Low $109.28    EPS $ 
Volume 788,345